 David Clouthier
Concepts (306)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neural Crest | 25 | 2023 | 117 | 3.720 |
Why?
| | Gene Expression Regulation, Developmental | 26 | 2021 | 814 | 2.840 |
Why?
| | Endothelin-1 | 13 | 2023 | 168 | 2.830 |
Why?
| | Receptor, Endothelin A | 15 | 2020 | 60 | 2.620 |
Why?
| | Branchial Region | 14 | 2021 | 34 | 2.330 |
Why?
| | Ear Diseases | 3 | 2022 | 14 | 2.040 |
Why?
| | Craniofacial Abnormalities | 11 | 2021 | 58 | 1.900 |
Why?
| | Mandible | 10 | 2021 | 65 | 1.880 |
Why?
| | Body Patterning | 12 | 2021 | 131 | 1.840 |
Why?
| | Face | 10 | 2021 | 165 | 1.820 |
Why?
| | Skull | 9 | 2015 | 127 | 1.480 |
Why?
| | Morphogenesis | 7 | 2021 | 167 | 1.460 |
Why?
| | Signal Transduction | 18 | 2023 | 4709 | 1.410 |
Why?
| | Ear | 3 | 2022 | 33 | 1.410 |
Why?
| | Homeodomain Proteins | 9 | 2017 | 468 | 1.360 |
Why?
| | Endothelins | 3 | 2023 | 62 | 1.360 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 12 | 2022 | 219 | 1.310 |
Why?
| | Zebrafish Proteins | 9 | 2022 | 252 | 1.150 |
Why?
| | Integrases | 5 | 2017 | 123 | 0.960 |
Why?
| | Awards and Prizes | 2 | 2023 | 57 | 0.900 |
Why?
| | Mice | 47 | 2022 | 15520 | 0.890 |
Why?
| | Mandibulofacial Dysostosis | 2 | 2020 | 5 | 0.880 |
Why?
| | GATA3 Transcription Factor | 2 | 2021 | 26 | 0.870 |
Why?
| | Developmental Biology | 4 | 2023 | 18 | 0.830 |
Why?
| | Maxilla | 2 | 2021 | 29 | 0.810 |
Why?
| | Genomics | 2 | 2023 | 706 | 0.780 |
Why?
| | Zebrafish | 10 | 2022 | 434 | 0.780 |
Why?
| | Embryo, Mammalian | 7 | 2021 | 220 | 0.700 |
Why?
| | Animals | 53 | 2022 | 33381 | 0.690 |
Why?
| | Transcription Factors | 13 | 2022 | 1570 | 0.670 |
Why?
| | Endothelin-Converting Enzymes | 4 | 2017 | 10 | 0.640 |
Why?
| | Maxillofacial Development | 4 | 2015 | 20 | 0.630 |
Why?
| | Receptors, Endothelin | 5 | 2003 | 49 | 0.620 |
Why?
| | Gene Deletion | 4 | 2009 | 361 | 0.610 |
Why?
| | Homeobox Protein Nkx-2.5 | 1 | 2017 | 3 | 0.600 |
Why?
| | Enhancer Elements, Genetic | 5 | 2016 | 152 | 0.570 |
Why?
| | Mice, Knockout | 14 | 2020 | 2680 | 0.550 |
Why?
| | MicroRNAs | 2 | 2015 | 637 | 0.540 |
Why?
| | Genetic Techniques | 1 | 2015 | 60 | 0.510 |
Why?
| | In Situ Hybridization | 10 | 2015 | 311 | 0.500 |
Why?
| | Pandemics | 2 | 2022 | 1355 | 0.490 |
Why?
| | Mice, Transgenic | 14 | 2019 | 2025 | 0.430 |
Why?
| | Tongue | 2 | 2019 | 73 | 0.430 |
Why?
| | Ectoderm | 1 | 2012 | 43 | 0.430 |
Why?
| | DNA-Binding Proteins | 8 | 2015 | 1346 | 0.420 |
Why?
| | Jaw | 5 | 2011 | 15 | 0.410 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2275 | 0.390 |
Why?
| | Disease Models, Animal | 3 | 2015 | 3730 | 0.380 |
Why?
| | Fishes | 1 | 2010 | 85 | 0.380 |
Why?
| | Endothelin A Receptor Antagonists | 1 | 2009 | 24 | 0.340 |
Why?
| | Pharynx | 4 | 2017 | 53 | 0.320 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2008 | 41 | 0.310 |
Why?
| | Models, Biological | 5 | 2017 | 1715 | 0.280 |
Why?
| | Heart Defects, Congenital | 5 | 2015 | 703 | 0.280 |
Why?
| | Phenotype | 4 | 2022 | 3003 | 0.260 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 4 | 1999 | 32 | 0.260 |
Why?
| | Congresses as Topic | 2 | 2023 | 204 | 0.250 |
Why?
| | Up-Regulation | 2 | 2017 | 872 | 0.230 |
Why?
| | Palate | 2 | 2015 | 30 | 0.220 |
Why?
| | Phospholipase C beta | 1 | 2022 | 26 | 0.210 |
Why?
| | Base Sequence | 11 | 2016 | 2159 | 0.210 |
Why?
| | Hedgehog Proteins | 3 | 2019 | 175 | 0.210 |
Why?
| | Cardiovascular System | 1 | 2003 | 127 | 0.210 |
Why?
| | Mesothelioma | 1 | 2022 | 32 | 0.210 |
Why?
| | Humans | 22 | 2023 | 118974 | 0.200 |
Why?
| | Mice, Inbred C57BL | 11 | 2019 | 4908 | 0.190 |
Why?
| | Prenatal Care | 1 | 2023 | 252 | 0.190 |
Why?
| | Zygoma | 2 | 2017 | 11 | 0.190 |
Why?
| | Brain | 3 | 2015 | 2490 | 0.190 |
Why?
| | GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2020 | 14 | 0.190 |
Why?
| | Loss of Function Mutation | 1 | 2020 | 42 | 0.180 |
Why?
| | Cell Death | 1 | 2021 | 339 | 0.180 |
Why?
| | Cell Proliferation | 2 | 2021 | 2275 | 0.180 |
Why?
| | Embryo, Nonmammalian | 2 | 2012 | 176 | 0.180 |
Why?
| | Bone and Bones | 2 | 2013 | 289 | 0.180 |
Why?
| | Glycogen Debranching Enzyme System | 1 | 2019 | 3 | 0.170 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2019 | 137 | 0.170 |
Why?
| | Software | 2 | 2022 | 613 | 0.170 |
Why?
| | Fetus | 1 | 2023 | 690 | 0.170 |
Why?
| | Mice, Inbred Strains | 2 | 2012 | 405 | 0.160 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 1997 | 11 | 0.160 |
Why?
| | Lipodystrophy | 1 | 1997 | 18 | 0.160 |
Why?
| | Organogenesis | 3 | 2018 | 54 | 0.150 |
Why?
| | Sp7 Transcription Factor | 1 | 2017 | 8 | 0.150 |
Why?
| | Molecular Sequence Data | 8 | 2016 | 2871 | 0.150 |
Why?
| | Glomerulosclerosis, Focal Segmental | 1 | 1997 | 39 | 0.150 |
Why?
| | Serrate-Jagged Proteins | 1 | 2017 | 30 | 0.150 |
Why?
| | Polymerase Chain Reaction | 4 | 2015 | 1012 | 0.150 |
Why?
| | Spermatogonia | 1 | 1996 | 11 | 0.140 |
Why?
| | Receptors, Notch | 1 | 2017 | 85 | 0.140 |
Why?
| | RNA, Messenger | 7 | 2015 | 2657 | 0.140 |
Why?
| | Mice, Mutant Strains | 3 | 2015 | 280 | 0.140 |
Why?
| | Spermatogenesis | 1 | 1996 | 53 | 0.140 |
Why?
| | Point Mutation | 2 | 2015 | 228 | 0.140 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2019 | 211 | 0.140 |
Why?
| | Transplantation, Heterologous | 1 | 1996 | 194 | 0.140 |
Why?
| | Skull Base | 1 | 2015 | 44 | 0.140 |
Why?
| | Facial Bones | 1 | 2015 | 33 | 0.130 |
Why?
| | Animals, Genetically Modified | 2 | 2012 | 225 | 0.130 |
Why?
| | Microscopy, Confocal | 3 | 2012 | 314 | 0.130 |
Why?
| | Cleft Palate | 1 | 2015 | 48 | 0.130 |
Why?
| | Histone Demethylases | 1 | 2015 | 28 | 0.130 |
Why?
| | Vestibular Diseases | 1 | 2015 | 22 | 0.130 |
Why?
| | Alopecia | 1 | 2015 | 34 | 0.130 |
Why?
| | Embryonic Development | 2 | 2007 | 118 | 0.130 |
Why?
| | 3' Untranslated Regions | 1 | 2015 | 142 | 0.130 |
Why?
| | Transforming Growth Factor beta | 1 | 1997 | 462 | 0.130 |
Why?
| | Hematologic Diseases | 1 | 2015 | 60 | 0.130 |
Why?
| | Repressor Proteins | 1 | 1998 | 377 | 0.130 |
Why?
| | DNA Copy Number Variations | 1 | 2015 | 167 | 0.130 |
Why?
| | Chickens | 1 | 2015 | 185 | 0.130 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2015 | 112 | 0.120 |
Why?
| | Basal Cell Nevus Syndrome | 1 | 2013 | 5 | 0.120 |
Why?
| | Models, Genetic | 2 | 2015 | 595 | 0.120 |
Why?
| | Nuclear Proteins | 2 | 2015 | 597 | 0.120 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2012 | 155 | 0.120 |
Why?
| | Osteogenesis | 1 | 2015 | 213 | 0.120 |
Why?
| | Abnormalities, Multiple | 1 | 2015 | 181 | 0.120 |
Why?
| | Craniosynostoses | 1 | 2013 | 28 | 0.120 |
Why?
| | Transcriptome | 1 | 2018 | 756 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2015 | 404 | 0.110 |
Why?
| | Transcription, Genetic | 3 | 2015 | 1323 | 0.110 |
Why?
| | beta-Galactosidase | 1 | 2012 | 65 | 0.110 |
Why?
| | Multigene Family | 1 | 2012 | 200 | 0.100 |
Why?
| | Neoplasm Proteins | 1 | 2015 | 401 | 0.100 |
Why?
| | Cell Division | 2 | 2004 | 776 | 0.100 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1308 | 0.100 |
Why?
| | Receptors, Cell Surface | 1 | 2013 | 367 | 0.100 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2011 | 52 | 0.100 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 311 | 0.100 |
Why?
| | Luminescent Proteins | 1 | 2012 | 174 | 0.100 |
Why?
| | Aspartic Acid Endopeptidases | 3 | 2000 | 22 | 0.100 |
Why?
| | Mutation | 6 | 2015 | 3457 | 0.100 |
Why?
| | Genes, Homeobox | 1 | 2010 | 51 | 0.100 |
Why?
| | Societies, Scientific | 2 | 2021 | 49 | 0.090 |
Why?
| | Tumor Suppressor Proteins | 1 | 2012 | 289 | 0.090 |
Why?
| | Down-Regulation | 2 | 2011 | 627 | 0.090 |
Why?
| | Aorta, Thoracic | 2 | 2005 | 248 | 0.090 |
Why?
| | Gene Expression Profiling | 2 | 2019 | 1597 | 0.090 |
Why?
| | Neurons | 2 | 2008 | 1345 | 0.090 |
Why?
| | Isoxazoles | 1 | 2009 | 56 | 0.080 |
Why?
| | DNA Primers | 4 | 2012 | 533 | 0.080 |
Why?
| | Transgenes | 1 | 2009 | 174 | 0.080 |
Why?
| | Research | 1 | 2011 | 411 | 0.080 |
Why?
| | Retinal Ganglion Cells | 1 | 2008 | 92 | 0.080 |
Why?
| | Sympathetic Nervous System | 1 | 2008 | 171 | 0.070 |
Why?
| | Genotype | 4 | 2015 | 1882 | 0.070 |
Why?
| | Computational Biology | 1 | 2011 | 588 | 0.070 |
Why?
| | Enteric Nervous System | 1 | 2007 | 26 | 0.070 |
Why?
| | Mesoderm | 2 | 2019 | 141 | 0.070 |
Why?
| | Sequence Analysis, RNA | 2 | 2019 | 409 | 0.070 |
Why?
| | Adipose Tissue | 4 | 1999 | 606 | 0.070 |
Why?
| | Alleles | 1 | 2009 | 832 | 0.070 |
Why?
| | Databases, Factual | 1 | 2011 | 1231 | 0.070 |
Why?
| | Time Factors | 2 | 2009 | 6412 | 0.070 |
Why?
| | Syndrome | 2 | 2015 | 344 | 0.070 |
Why?
| | Metalloendopeptidases | 3 | 2000 | 56 | 0.070 |
Why?
| | United States | 1 | 2022 | 12555 | 0.070 |
Why?
| | Sulfonamides | 1 | 2009 | 445 | 0.070 |
Why?
| | Cell Line | 1 | 2011 | 2707 | 0.070 |
Why?
| | Egtazic Acid | 1 | 2004 | 44 | 0.060 |
Why?
| | Exons | 2 | 2015 | 307 | 0.060 |
Why?
| | Cells, Cultured | 1 | 2012 | 4077 | 0.060 |
Why?
| | Mast Cells | 1 | 2004 | 115 | 0.060 |
Why?
| | Morpholinos | 2 | 2015 | 30 | 0.060 |
Why?
| | Female | 13 | 2023 | 61565 | 0.060 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2000 | 290 | 0.060 |
Why?
| | Child | 1 | 2023 | 19129 | 0.060 |
Why?
| | Chimera | 1 | 2003 | 60 | 0.060 |
Why?
| | Helix-Loop-Helix Motifs | 1 | 2003 | 11 | 0.060 |
Why?
| | Odontoblasts | 1 | 2003 | 2 | 0.060 |
Why?
| | Antigens, Viral, Tumor | 1 | 2003 | 5 | 0.060 |
Why?
| | Male | 11 | 2019 | 57801 | 0.060 |
Why?
| | Pregnancy | 5 | 2023 | 5691 | 0.050 |
Why?
| | Sequence Deletion | 1 | 2003 | 171 | 0.050 |
Why?
| | Forkhead Transcription Factors | 2 | 2019 | 182 | 0.050 |
Why?
| | Rats | 5 | 1999 | 5392 | 0.050 |
Why?
| | Gestational Age | 1 | 2005 | 765 | 0.050 |
Why?
| | Hepatocytes | 1 | 2003 | 205 | 0.050 |
Why?
| | Workflow | 1 | 2023 | 148 | 0.050 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2004 | 245 | 0.050 |
Why?
| | Trans-Activators | 1 | 2004 | 373 | 0.050 |
Why?
| | Cell Lineage | 1 | 2003 | 318 | 0.050 |
Why?
| | Genetics, Medical | 1 | 2021 | 26 | 0.050 |
Why?
| | Apoptosis | 2 | 2003 | 2484 | 0.050 |
Why?
| | Epithelium | 1 | 2022 | 305 | 0.050 |
Why?
| | Viral Proteins | 1 | 2003 | 296 | 0.050 |
Why?
| | Homeostasis | 1 | 2004 | 594 | 0.050 |
Why?
| | Gene Expression Regulation | 3 | 2008 | 2445 | 0.050 |
Why?
| | Videoconferencing | 1 | 2021 | 59 | 0.050 |
Why?
| | Fetal Heart | 1 | 2000 | 29 | 0.050 |
Why?
| | Genetic Testing | 1 | 2023 | 389 | 0.050 |
Why?
| | Genes, Reporter | 2 | 2016 | 270 | 0.050 |
Why?
| | Xenopus | 1 | 2020 | 104 | 0.050 |
Why?
| | Butylhydroxybutylnitrosamine | 1 | 2019 | 6 | 0.040 |
Why?
| | DNA, Complementary | 2 | 2015 | 268 | 0.040 |
Why?
| | Bone Morphogenetic Protein 4 | 1 | 2019 | 34 | 0.040 |
Why?
| | Genetic Engineering | 1 | 2019 | 83 | 0.040 |
Why?
| | Goosecoid Protein | 1 | 1998 | 1 | 0.040 |
Why?
| | Tretinoin | 1 | 1999 | 116 | 0.040 |
Why?
| | Career Choice | 1 | 2020 | 192 | 0.040 |
Why?
| | Mice, Obese | 1 | 1997 | 58 | 0.040 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 1999 | 195 | 0.040 |
Why?
| | Aspartate Aminotransferases | 1 | 1997 | 95 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2019 | 481 | 0.040 |
Why?
| | Alanine Transaminase | 1 | 1997 | 152 | 0.040 |
Why?
| | Societies, Medical | 1 | 2021 | 703 | 0.040 |
Why?
| | Recombinant Fusion Proteins | 2 | 1997 | 653 | 0.040 |
Why?
| | Seminiferous Tubules | 1 | 1996 | 10 | 0.040 |
Why?
| | GATA Transcription Factors | 1 | 2016 | 8 | 0.040 |
Why?
| | Smad Proteins | 1 | 2016 | 39 | 0.040 |
Why?
| | Ethylnitrosourea | 1 | 2015 | 10 | 0.040 |
Why?
| | Genes, Recessive | 1 | 2015 | 73 | 0.030 |
Why?
| | Animals, Newborn | 1 | 1998 | 806 | 0.030 |
Why?
| | Mice, SCID | 1 | 1996 | 333 | 0.030 |
Why?
| | Markov Chains | 1 | 2015 | 118 | 0.030 |
Why?
| | Cell Movement | 1 | 2000 | 896 | 0.030 |
Why?
| | Collagen | 1 | 1997 | 433 | 0.030 |
Why?
| | Phosphorylation | 2 | 2014 | 1633 | 0.030 |
Why?
| | Mutagenesis | 1 | 2015 | 176 | 0.030 |
Why?
| | DNA | 3 | 1997 | 1388 | 0.030 |
Why?
| | Twist-Related Protein 1 | 1 | 2014 | 10 | 0.030 |
Why?
| | Chick Embryo | 2 | 2007 | 129 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 1999 | 1158 | 0.030 |
Why?
| | Fibroblast Growth Factor 8 | 1 | 2014 | 27 | 0.030 |
Why?
| | Species Specificity | 1 | 2015 | 565 | 0.030 |
Why?
| | Kidney | 3 | 1997 | 1353 | 0.030 |
Why?
| | Cartilage | 1 | 2015 | 183 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 333 | 0.030 |
Why?
| | Patched Receptors | 1 | 2013 | 11 | 0.030 |
Why?
| | Exome | 1 | 2015 | 220 | 0.030 |
Why?
| | Patched-1 Receptor | 1 | 2013 | 15 | 0.030 |
Why?
| | Pedigree | 1 | 2015 | 485 | 0.030 |
Why?
| | Liver | 3 | 1997 | 1816 | 0.030 |
Why?
| | Feasibility Studies | 1 | 1996 | 749 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2014 | 161 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2015 | 770 | 0.030 |
Why?
| | Skin | 1 | 1997 | 657 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2015 | 300 | 0.030 |
Why?
| | Embryo Implantation | 1 | 1992 | 24 | 0.030 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 1992 | 30 | 0.030 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 1992 | 82 | 0.030 |
Why?
| | Cytosol | 1 | 1992 | 221 | 0.030 |
Why?
| | Fetal Death | 2 | 2005 | 52 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 755 | 0.030 |
Why?
| | Receptors, Immunologic | 1 | 1992 | 209 | 0.030 |
Why?
| | Trophoblasts | 1 | 1992 | 170 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 1996 | 2478 | 0.020 |
Why?
| | Gene Targeting | 2 | 2003 | 80 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2012 | 709 | 0.020 |
Why?
| | Immunohistochemistry | 2 | 2008 | 1691 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2015 | 2062 | 0.020 |
Why?
| | Pseudopregnancy | 1 | 2007 | 3 | 0.020 |
Why?
| | Chromosomes, Artificial, Bacterial | 1 | 2007 | 20 | 0.020 |
Why?
| | Vasoactive Intestinal Peptide | 1 | 2007 | 24 | 0.020 |
Why?
| | Choline O-Acetyltransferase | 1 | 2007 | 23 | 0.020 |
Why?
| | Membrane Proteins | 1 | 1992 | 1055 | 0.020 |
Why?
| | Growth Hormone | 2 | 1999 | 108 | 0.020 |
Why?
| | Cohort Studies | 1 | 2015 | 5116 | 0.020 |
Why?
| | Truncus Arteriosus, Persistent | 1 | 2005 | 6 | 0.020 |
Why?
| | Stem Cells | 2 | 2004 | 559 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2015 | 2436 | 0.020 |
Why?
| | Chymases | 1 | 2004 | 3 | 0.020 |
Why?
| | Cell Degranulation | 1 | 2004 | 38 | 0.020 |
Why?
| | Injections, Intraperitoneal | 1 | 2004 | 108 | 0.020 |
Why?
| | Gastrointestinal Tract | 1 | 2007 | 175 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2004 | 64 | 0.020 |
Why?
| | Transfection | 1 | 2007 | 888 | 0.020 |
Why?
| | Serine Endopeptidases | 1 | 2004 | 105 | 0.020 |
Why?
| | Peritonitis | 1 | 2004 | 79 | 0.020 |
Why?
| | Body Temperature | 1 | 2004 | 215 | 0.010 |
Why?
| | Diarrhea | 1 | 2004 | 181 | 0.010 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2003 | 10 | 0.010 |
Why?
| | Embryonic Induction | 1 | 2003 | 30 | 0.010 |
Why?
| | Peptides, Cyclic | 1 | 2004 | 260 | 0.010 |
Why?
| | Oligopeptides | 1 | 2004 | 252 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 982 | 0.010 |
Why?
| | Caspases | 1 | 2003 | 269 | 0.010 |
Why?
| | Organ Specificity | 2 | 1992 | 278 | 0.010 |
Why?
| | COS Cells | 1 | 2001 | 184 | 0.010 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2003 | 227 | 0.010 |
Why?
| | Cell Survival | 1 | 2004 | 1047 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2003 | 420 | 0.010 |
Why?
| | Endothelin-2 | 1 | 2000 | 2 | 0.010 |
Why?
| | Survival Rate | 1 | 2004 | 1720 | 0.010 |
Why?
| | Body Weight | 1 | 2004 | 934 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2000 | 334 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2003 | 618 | 0.010 |
Why?
| | Base Pairing | 1 | 1999 | 59 | 0.010 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2003 | 455 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2001 | 823 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2003 | 726 | 0.010 |
Why?
| | Binding Sites | 1 | 2001 | 1224 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2000 | 1094 | 0.010 |
Why?
| | Adipocytes | 1 | 1999 | 199 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2003 | 1167 | 0.010 |
Why?
| | Cell Nucleus | 1 | 1999 | 580 | 0.010 |
Why?
| | Protein Binding | 1 | 2001 | 1975 | 0.010 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 1992 | 14 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1992 | 194 | 0.010 |
Why?
| | Endocytosis | 1 | 1992 | 156 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 1992 | 381 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1992 | 546 | 0.010 |
Why?
| | Glucocorticoids | 1 | 1992 | 545 | 0.000 |
Why?
| | RNA | 1 | 1992 | 833 | 0.000 |
Why?
| | Diet | 1 | 1992 | 1153 | 0.000 |
Why?
|
|
Clouthier's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|